Pancreatic Cancer: Promises and Failures of Target Therapies

被引：7
|
作者：
Aroldi, Francesca [1 ]
Bertocchi, Paola [1 ]
Rosso, Edoardo [2 ]
Prochilo, Tiziana [1 ]
Zaniboni, Alberto [1 ]
机构：
[1] Fdn Poliambulanza, UO Oncol Med, Brescia, Italy
[2] Fdn Poliambulanza, Dept Surg, Brescia, Italy
来源：
REVIEWS ON RECENT CLINICAL TRIALS | 2016年 / 11卷 / 01期
关键词：
Angiogenesis; hedgehog-; JAK-STAT; -notch; immunotherapy; pancreatic cancer; stroma; target therapies;
D O I：
10.2174/1574887110666150930122720
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Currently, few efficient therapies are available to battle pancreatic cancer. Mechanisms underlying this cancer are not well known and researchers are trying to identify new therapeutic targets. Here, we present a review of new treatments and their results in recent years.
引用
收藏
页码：33 / 38
页数：6
相关论文
共 50 条
  • [1] Targeted therapies in pancreatic cancer: Promises and failures
    Bagherabad, Matineh Barati
    Afzaljavan, Fahimeh
    ShahidSales, Soodabeh
    Hassanian, Seyed Mahdi
    Avan, Amir
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 2726 - 2741
  • [2] Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies
    Bahrami, Afsane
    Khazaei, Majid
    Bagherieh, Fariba
    Ghayour-Mobarhan, Majid
    Maftouh, Mina
    Hassanian, Seyed Mahdi
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (11) : 2931 - 2937
  • [3] New target therapies in advanced pancreatic cancer
    Cascinu, S.
    Verdecchia, L.
    Valeri, N.
    Berardi, R.
    Scartozzi, M.
    ANNALS OF ONCOLOGY, 2006, 17 : V148 - V152
  • [4] Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies
    Abrantes, Rafaela
    Lopes, Joanne
    Lopes, Daniel
    Gomes, Joana
    Melo, Sonia A.
    Reis, Celso A.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies?
    Halle-Smith, James M.
    Hall, Lewis A.
    Powell-Brett, Sarah F.
    Merali, Nabeel
    Frampton, Adam E.
    Beggs, Andrew D.
    Moss, Paul
    Roberts, Keith J.
    CANCERS, 2023, 15 (21)
  • [6] The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
    Curcio, Claudia
    Brugiapaglia, Silvia
    Bulfamante, Sara
    Follia, Laura
    Cappello, Paola
    Novelli, Francesco
    MOLECULES, 2021, 26 (06):
  • [7] Novel treatments and therapies in development for pancreatic cancer
    Günzburg, WH
    Löhr, M
    Salmons, B
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (06) : 769 - 786
  • [8] Novel Approaches to Target Pancreatic Cancer
    Porzner, M.
    Seufferlein, T.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (06) : 698 - 713
  • [9] Targeted Therapies for Pancreatic Cancer
    Ma, Qingyong
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (17) : 2393 - 2394
  • [10] Targeted therapies for pancreatic cancer
    Danovi, S. A.
    Wong, H. H.
    Lemoine, N. R.
    BRITISH MEDICAL BULLETIN, 2008, 87 (01) : 97 - 130
12345